p53 isoforms can regulate p53 transcriptional activity

Genes and Development

Volumn 19, Issue 18, 2005, Pages 2122-2137

  Bourdon, Jean Christophe ^a   Fernandes, Kenneth ^a   Murray Zmijewski, Fiona ^a   Liu, Geng ^a   Diot, Alexandra ^a   Xirodimas, Dimitris P ^a   Saville, Mark K ^a   Lane, David P ^a,b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

Cancer; Drosophila; p63; p73; Promoter; Splice

Indexed keywords

ISOPROTEIN; PROTEIN P53; PROTEIN P63; PROTEIN P73; PROTEIN SUBUNIT;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DROSOPHILA; GENE ACTIVITY; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSECT GENETICS; MOLECULAR EVOLUTION; MOUSE; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DROSOPHILA; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, INSECT; GENES, P53; GENES, REPORTER; HT29 CELLS; HUMANS; INTRONS; LUCIFERASES; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; VARIATION (GENETICS);

EID: 24344448786     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1339905     Document Type: Article

References (41)

1. Almog, N., Goldfinger, N., and Rotter, V. 2000. p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53. Oncogene 19: 3395-3403.
2. Bates, G.J., Nicol, S.M., Wilson, B.J., Jacobs, A.M., Bourdon, J.C., Wardrop, J., Gregory, D.J., Lane, D.P., Perkins, N.D., and Fuller-Pace, F.V. 2005. The DEAD box protein p68: A novel transcriptional coactivator of the p53 tumour suppressor. EMBO J. 24: 543-553. [Epub 2005 January 20.]
3. Benard, J., Douc-Rasy, S., and Ahomadegbe, J.C. 2003. TP53 family members and human cancers. Hum. Mutat. 21: 182-191.
4. Bienz-Tadmor, B., Zakut-Houri, R., Libresco, S., Givol, D., and Oren, M. 1985. The 5′ region of the p53 gene: Evolutionary conservation and evidence for a negative regulatory element. EMBO J. 4: 3209-3213.
5. Bourdon, J.-C., Renzing, J., Robertson, P.L., Fernandes, K.N., and Lane, D.P. 2002. Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane. J. Cell. Biol. 158: 235-246. [Epub 2002 July 22.]
6. Brodsky, M.H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G.M., and Abrams, J.M. 2000. Drosophila p53 binds a damage response element at the reaper locus. Cell 101: 103-113.
7. Courtois, S., Verhaegh, G., North, S., Luciani, M.G., Lassus, P., Hibner, U., Oren, M., and Hainaut, P. 2002. ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene 21: 6722-6728.
8. Deguin-Chambon, V., Vacher, M., Jullien, M., May, E., and Bourdon, J.C. 2000. Direct transactivation of c-Ha-Ras gene by p53: Evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis. Oncogene 19: 5831-5841.
9. De Leo, A.B., Jay, G., Appella, E., Dubois, G.C., Law, L.W., and Old, L.J. 1979. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc. Natl. Acad. Sci. 76: 2420-2424.
10. Dohn, M., Zhang, S., and Chen, X. 2001. αp63 and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20: 3193-3205.
11. Flaman, J.-M., Waridel, F., Estreicher, A., Vannier, A., Limacher, J.-M., Gilbert, D., Iggo, R., and Frebourg, T. 1996. The human tumor suppressor gene p53 is alternatively spliced in normal cells. Oncogene 12: 813-818.
12. Ghosh, A., Stewart, D., and Matlashewski, G. 2004. Regulation of human p53 activity and cell localization by alternative splicing. Mol. Cell. Biol. 24: 7987-7997.
13. Goldschneider, D., Million, K., Meiller, A., Haddada, H., Puisieux, A., Benard, J., May, E., and Douc-Rasy, S. 2005. The neurogene BTG2TIS21/PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells. J. Cell Sci. 118: 1245-1253. [Epub 2005 March 1.]
14. Harlow, E. and Lane, D.P. 1988. Antibodies: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
15. Harms, K.L. and Chen, X. 2005. The C terminus of p53 family proteins is a cell fate determinant. Mol. Cell. Biol. 25: 2014-2030.
16. Jin, S., Martinek, S., Joo, W.S., Wortman, J.R., Mirkovic, N., Sali, A., Yandell, M.D., Pavletich, N.P., Young, M.W., and Levine, A.J. 2000. Identification and characterization of a p53 homologue in Drosophila melanogaster. Proc. Natl. Acad. Sci. 97: 7301-7306.
17. Kaeser, M.D. and Iggo, R.D. 2002. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. 99: 95-100. [Epub 2001 December 26.]
18. Kress, M., May, E., Cassingena, R., and May, P. 1979. Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J. Virol. 31: 472-483.
19. Lamb, P. and Crawford, L. 1986. Characterization of the human p53 gene. Mol. Cell. Biol. 6: 1379-1385.
20. Lane, D.P. and Crawford, L.V. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261-263.
21. Linzer, D.I.H. and Levine, A.J. 1979. Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40-transformed cells and in infected embryonal carcinoma cells. Cell 1: 43-52.
22. Liu, W.L., Midgley, C., Stephen, C., Saville, M., and Lane, D.P. 2001. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein. J. Mol. Biol. 313: 711-731.
23. Liu, G., Nozell, S., Xiao, H., and Chen, X. 2004. ΔNp73β is active in transactivation and growth suppression. Mol. Cell. Biol. 24: 487-501.
24. Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., and Scrable, H. 2004. Modulation of mammalian life span by the short isoform of p53. Genes & Dev. 18: 306-319.
25. Melero, J.A., Stitt, D.T., Mangel, W.F., and Carroll, R.B. 1979. Identification of new polypeptide species (48-55K) immunoprecipitable by antiserum to purified large T antigen and present in simian virus 40-infected and transformed cells. J. Virol. 93: 466-480.
26. Melino, G., Lu, X., Gasco, M., Crook, T., and Knight, R.A. 2003. Functional regulation of p73 and p63: Development and cancer. Trends Biochem. Sci. 28: 663-670.
27. Midgley, C.A., Fisher, C.J., Bartek, J., Vojtesek, B., Lane, D., and Barnes, D.M. 1992. Analysis of p53 expression in human tumours: An antibody raised against human p53 expressed in Escherichia coli. J. Cell Sci. 101: 183-189.
28. Ollmann, M., Young, L.M., Di Como, C.J., Karim, F., Belvin, M., Robertson, S., Whittaker, K., Demsky, M., Fisher, W.W., Buchman, A., et al. 2000. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 101: 91-101.
29. Oren, M. 2003. Decision making by p53: Life, death and cancer. Cell Death Differ. 1: 431-442.
30. Renzing, J. and Lane, D.P. 1995. p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts. Oncogene 10: 1865-1868.
31. Stephen, C.W., Helminen, P., and Lane, D.P. 1995. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: Insights into antibody-peptide interactions. J. Mol. Biol. 248: 58-78.
32. Tyner, S.D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53.
33. Vojtesek, B., Dolezalova, H., Lauerova, L., Svitakova, M., Havlis, P., Kovarik, J., Midgley, C.A., and Lane, D.P. 1995. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein. Oncogene 10: 389-393.
34. Wolf, D., Harris, N., Goldfinger, N., and Rotter, V. 1985. Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule. Mol. Cell. Biol. 5: 127-132.
35. Wu, Y., Liu, Y., Lee, L., Miner, Z., and Kulesz-Martin, M. 1994. Wild-type alternatively spliced p53: Binding to DNA and interaction with the major p53 protein in vitro and in cells. EMBO J. 13: 4823-4830.
36. Wu, G., Nomoto, S., Hoque, M.O., Dracheva, T., Osada, M., Lee, C.C., Dong, S.M., Guo, Z., Benoit, N., Cohen, Y., et al. 2003. ΔNp63α and TAp63α regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 63: 2351-2357.
37. Xirodimas, D.P., Saville, M.K., Bourdon, J.-C., Hay, R.T., and Lane, D.P. 2004. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118: 83-97.
38. Yang, A., Kaghad, M., Caput, D., and McKeon, F. 2002. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 18: 90-95.
39. Yin, Y., Stephen, C.W., Luciani, M.G., and Fahraeus, R. 2002. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat. Cell Biol. 4: 462-467.
40. Zhu, J., Zhou, W., Jiang, J., and Chen, X. 1998. Identification of a novel p53 functional domain that is necessary for mediating apoptosis. J. Biol. Chem. 273: 13030-13036.
41. Zhu, J., Zhang, S., Jiang, J., and Chen, X. 2000. Definition of the p53 functional domains necessary for inducing apoptosis. J. Biol. Chem. 275: 39927-39934.